Cong F. Luo

No. 639 Zhizaoju Road
Shanghai, 200011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Tailoring the Electron-Enriched Microenvironment of UiO-66 via Thiol Functionalization to Boost Non-Thermal Plasma CO2 Conversion.

Tailoring the Electron-Enriched Microenvironment of UiO-66 via Thiol Functionalization to Boost Non-Thermal Plasma CO2 Conversion.

Journal: Inorganic chemistry

Published: July 05, 2026

Assembly Module-Empowering Lipid-Prodrug Nanoamplifier for Enhancing Ferroptosis-Driven Cancer Treatment.

Assembly Module-Empowering Lipid-Prodrug Nanoamplifier for Enhancing Ferroptosis-Driven Cancer Treatment.

Journal: Nano letters

Published: March 13, 2026

Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial.

Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial.

Journal: Journal of hepatology

Published: October 28, 2025

Microbial-Engineered Fluorescent Nanocarrier for Ion Ratiometric Sensing and sTREM-1-Mediated EBV Inhibition.

Microbial-Engineered Fluorescent Nanocarrier for Ion Ratiometric Sensing and sTREM-1-Mediated EBV Inhibition.

Journal: Luminescence : the journal of biological and chemical luminescence

Published: September 11, 2025

Cell Surface Ion-Seq: Potassium Ion Monitoring in the Colorectal Cancer Cellular Microenvironment Based on Split G‑quadruplex Probe.

Cell Surface Ion-Seq: Potassium Ion Monitoring in the Colorectal Cancer Cellular Microenvironment Based on Split G‑quadruplex Probe.

Journal: ACS central science

Published: August 07, 2025

Engineering Lanthanide Ion-Labeled Aptamers for ICP-MS Profiling of Serum-Derived Extracellular Vesicles from Colorectal Cancer.

Engineering Lanthanide Ion-Labeled Aptamers for ICP-MS Profiling of Serum-Derived Extracellular Vesicles from Colorectal Cancer.

Journal: JACS Au

Published: May 26, 2025

The malignant dialogue between cancer-associated fibroblasts and osteosarcoma cells: microenvironment-mediated drug resistance and therapeutic targets.

The malignant dialogue between cancer-associated fibroblasts and osteosarcoma cells: microenvironment-mediated drug resistance and therapeutic targets.

Journal: Frontiers in immunology

Published: May 01, 2025

UBE2D2 promotes gastric cancer progression by inhibiting ferroptosis through autophagy-dependent stabilization of CST1.

UBE2D2 promotes gastric cancer progression by inhibiting ferroptosis through autophagy-dependent stabilization of CST1.

Journal: International journal of biological macromolecules

Published: April 15, 2025

FXR activation suppresses NF-κB signaling, proliferation and migration in cervical cancer cells.

FXR activation suppresses NF-κB signaling, proliferation and migration in cervical cancer cells.

Journal: Translational cancer research

Published: March 06, 2025

The prognostic impact of surufatinib for the treatment of advanced pancreatic ductal adenocarcinoma: a single center real-world retrospective study.

The prognostic impact of surufatinib for the treatment of advanced pancreatic ductal adenocarcinoma: a single center real-world retrospective study.

Journal: Frontiers in oncology

Published: February 11, 2025

Evaluating cadonilimab efficacy and safety in retrospective first line treatment for advanced pancreatic cancer.

Evaluating cadonilimab efficacy and safety in retrospective first line treatment for advanced pancreatic cancer.

Journal: iScience

Published: December 31, 2024

On-Site Self-Penetrating Nanomedicine Enabling Dual-Priming Drug Activation and Inside-Out Thrombus Ablation.

On-Site Self-Penetrating Nanomedicine Enabling Dual-Priming Drug Activation and Inside-Out Thrombus Ablation.

Journal: ACS nano

Published: December 12, 2024

Showing 1-12 of 82

Last Updated: 09/26/2026